Similar articles for PMID: 23973697

Year	Number of Results
1986	1
1990	1
1994	1
2001	1
2002	1
2003	2
2004	6
2005	6
2006	3
2007	6
2008	8
2009	7
2010	8
2011	7
2012	1
2013	4
2014	4
2015	3
2016	2
2017	5
2020	1
2024	0

1

High-density lipoprotein and residual cardiovascular risk: De minimis non curat medicus or the COURAGE to be SMART?

Genest J. Genest J. J Am Coll Cardiol. 2013 Nov 12;62(20):1842-4. doi: 10.1016/j.jacc.2013.05.087. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973697 Free article. No abstract available.

2

Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.

van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL; SMART Study Group. van de Woestijne AP, et al. J Am Coll Cardiol. 2013 Nov 12;62(20):1834-41. doi: 10.1016/j.jacc.2013.04.101. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23948286 Free article.

3

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP, Kostuk W, Spertus JA, Dada M, Chaitman BR, Mancini GB, Weintraub WS. Acharjee S, et al. J Am Coll Cardiol. 2013 Nov 12;62(20):1826-33. doi: 10.1016/j.jacc.2013.07.051. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973693 Free PMC article.

4

Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.

Lavie CJ, Milani RV. Lavie CJ, et al. J Am Coll Cardiol. 2008 Jan 1;51(1):56-8. doi: 10.1016/j.jacc.2007.08.055. J Am Coll Cardiol. 2008. PMID: 18174037 Free article. No abstract available.

5

[Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].

Håkansson J. Håkansson J. Lakartidningen. 2011 Jun 1-14;108(22-23):1234-5. Lakartidningen. 2011. PMID: 21786497 Swedish. No abstract available.

6

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, Hiserote P, Clearfield MB. Cui Y, et al. Am J Cardiol. 2009 Sep 15;104(6):829-34. doi: 10.1016/j.amjcard.2009.05.020. Am J Cardiol. 2009. PMID: 19733719 Clinical Trial.

7

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators. Barter P, et al. N Engl J Med. 2007 Sep 27;357(13):1301-10. doi: 10.1056/NEJMoa064278. N Engl J Med. 2007. PMID: 17898099 Free article. Clinical Trial.

8

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Miller M. Miller M. N Engl J Med. 2004 Aug 12;351(7):714-7; author reply 714-7. N Engl J Med. 2004. PMID: 15309746 No abstract available.

9

Achieving cholesterol goals. Current and future drug therapies.

Jones PH. Jones PH. Postgrad Med. 2003 Aug;114(2 Suppl):14-21. doi: 10.3810/pgm.08.2003.suppl28.152. Postgrad Med. 2003. PMID: 19667635

10

Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.

Lama S, Souraya D, Youssef F. Lama S, et al. Int J Clin Pharm. 2017 Aug;39(4):919-926. doi: 10.1007/s11096-017-0483-x. Epub 2017 May 18. Int J Clin Pharm. 2017. PMID: 28523462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year